Severe Acute Respiratory Syndrome
Showing 26 - 50 of >10,000
SARS (Severe Acute Respiratory Syndrome), Cytokine Storm, ARDS, Human Trial in Germany, Sweden (Hyperbaric oxygen)
Terminated
- SARS (Severe Acute Respiratory Syndrome)
- +5 more
- Hyperbaric oxygen
-
Regensburg, Germany
- +2 more
Jan 5, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Trial (COVAC-2, Saline Placebo)
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVAC-2
- Saline Placebo
- (no location specified)
Aug 5, 2022
Influenza-like Illness (Including COVID-19)
Suspended
- Influenza
- +7 more
- Respiratory infections
-
London, United KingdomImperial College London
Jul 27, 2022
Thyroid Dysfunction, Hypothyroidism, Hyperthyroidism Trial in Riyadh (Thyroxine)
Completed
- Thyroid Dysfunction
- +2 more
-
Riyadh, Central, Saudi ArabiaSecurity Forces Hospital
May 18, 2022
Non-invasive Respiratory Support on Outcome and Its Risks in
Active, not recruiting
- COVID-19
- Hypoxemic Respiratory Failure
- High flow nasal oxygen (HFNO, more than 15 L/min)
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Sep 4, 2023
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial in Los Angeles (MBS-COV, Placebo)
Recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
-
Los Angeles, CaliforniaPhase I Unit
Jan 10, 2023
Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Distress Syndrome Trial in Paris (Umbilical cord
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- Severe Acute Respiratory Distress Syndrome
- Umbilical cord Wharton's jelly-derived human
- NaCl 0.9%
-
Paris, France
- +1 more
Feb 17, 2022
Critical Illness, Septic Shock, Vasogenic Shock Trial in Essen, Barcelona (CytoSorb)
Recruiting
- Critical Illness
- +11 more
- CytoSorb
-
Essen, North Rhine-Westphalia, Germany
- +1 more
Jul 20, 2022
Corona Virus Infection, Pneumonia, Ventilator-Associated Trial in Split (Inhalation of N-acetylcysteine, Inhalation of 5% sodium
Completed
- Corona Virus Infection
- Pneumonia, Ventilator-Associated
- Inhalation of N-acetylcysteine
- +2 more
-
Split, CroatiaClinical Hospital Centre Split
Feb 11, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Covid19, SARS (Severe Acute Respiratory Syndrome), SARS-CoV Infection Trial in Sao Paulo (Exercise training)
Recruiting
- Covid19
- +2 more
- Exercise training
-
Sao Paulo, BrazilUniversity of Sao Paulo
Jun 10, 2022
Northeast COVID-19 and Pregnancy Study Group
Active, not recruiting
- COVID19
- +3 more
-
Recife, Pernambuco, BrazilInstituto Materno Infantil Prof. Fernando Figueira
Aug 1, 2022
Severe Acute Respiratory Syndrome Corona Virus 2 Immune Kidney
Active, not recruiting
- Kidney Transplant Infection
- SARS-CoV Infection
- SARS-CoV-2 vaccine
-
Oslo, NorwayOslo University Hospital
Apr 19, 2022
Respiratory Viral Infection, Common Cold, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Vienna (nasal spray)
Completed
- Respiratory Viral Infection
- +4 more
- nasal spray
-
Vienna, Austria
- +1 more
Aug 24, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial (Hydroxychloroquine, Vitamins and Minerals, Azithromycin)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Hydroxychloroquine
- +2 more
- (no location specified)
Dec 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial (Favipiravir HU 200 mg hard capsules, Placebo HU)
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Favipiravir HU 200 mg hard capsules
- Placebo HU
-
Szeged, HungaryUniversity of Szeged - Internal Medicine
Nov 4, 2022
Acute Respiratory Distress Syndrome, Ventilator Lung Trial in Rotterdam (Flow-controlled ventilation)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Ventilator Lung
- Flow-controlled ventilation
-
Rotterdam, Zuid-Holland, NetherlandsMaasstad Hospital
Sep 20, 2023
SARS-CoV Infection, COVID-19 Trial (Mitoquinone/mitoquinol mesylate, Placebo)
Not yet recruiting
- SARS-CoV Infection
- COVID-19
- Mitoquinone/mitoquinol mesylate
- Placebo
- (no location specified)
Jun 1, 2023
Japan of Shock and Anaphylaxis After Severe Acute Respiratory
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd.
Jun 5, 2023
COVID-19, Severe Acute Respiratory Syndrome Trial in Mexico, City (Hydroxychloroquine, Placebo oral tablet)
Completed
- COVID-19
- Severe Acute Respiratory Syndrome
- Hydroxychloroquine
- Placebo oral tablet
-
Mexico, City, MexicoInstituto Nacional de Enfermedades Respiratorias, "Ismael Cosío
Jan 17, 2022
COVID-19, SARS-CoV Infection, SARS (Severe Acute Respiratory Syndrome) Trial in Mexico DF (Glycine)
Terminated
- COVID-19
- +5 more
- Glycine
-
Mexico DF, MexicoInstituto Nacional de Enfermedades Respiratorias
Aug 2, 2022
Post-COVID-19 Syndrome Trial in Istanbul (non-invasive auricular vagus stimulation, Placebo Non Invasive Vagus Stimulation)
Recruiting
- Post-COVID-19 Syndrome
- non-invasive auricular vagus stimulation
- Placebo Non Invasive Vagus Stimulation
-
Istanbul, Istanbul Avrupa Kitasi, TurkeyBahçeşehir University
Mar 10, 2023
SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver
Completed
- Non-Alcoholic Fatty Liver Disease
- SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) LIFESTYLE CHANGES
-
Naples, ItalyUniversity of Campania "Luigi Vanvitelli"
Jun 9, 2022
COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)
Not yet recruiting
- COVID 19 Disease
- +4 more
- Tafenoquine Oral Tablet
- Placebo
- (no location specified)
Jul 13, 2023